October 07, 2025

DEKA Research & Development Completes Acquisition of Diatech Diabetes Core Assets and IP

New York City, N.Y. and Manchester, N.H. [October 7, 2025] – DEKA Research & Development, developer of the new twiist® Automated Insulin Delivery (AID) system, has acquired the core assets and intellectual property of Diatech Diabetes, a medical device company developing technology to improve the safety of insulin infusion for people living with diabetes....

Leer en Español

June 22, 2023

Diatech Diabetes Receives Breakthrough T1D Award to Advance Novel Software Platform for Monitoring Insulin Pump Infusion Set Failure

Memphis, T.N. and New York, N.Y., June 22, 2023 – Diatech Diabetes, a medtech startup led by people with diabetes dedicated to developing personalized diabetes care technology, announced today an award from Breakthrough T1D through its Industry Discovery & Development Partnership (IDDP) program...

Leer en Español

Click Here for Official Breakthrough T1D Announcement

SEP 7, 2021

Diatech Diabetes, Inc. Awarded Phase 1 SBIR Grant for Preclinical Development of Innovative Infusion Monitoring and Failure Detection Insulin Pump Algorithm

Memphis, TN--September 07, 2021--Diatech Diabetes (Diatech) has announced today its reception of a $300,000 Phase 1 Small Business and Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases...

Leer en Español